Please use this identifier to cite or link to this item:
https://islhd.intersearch.com.au/islhdjspui/handle/1/6332| Title: | Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer |
| ISLHD Author: | Francis, Katherine E |
| Authors: | Francis KE;Simon S;Gebski V;Joly F;Ledermann JA;Penson RT;Oza AM;Korach J;Lainez N;Cecere SC;Tasca G;Gropp-Meier M;Fujiwara K;Lowe ES;Friedlander M;Pujade-Lauraine E;Lee CK |
| Keywords: | Ovarian Neoplasm |
| Date Published: | 1-Jan-2025 |
| Citation: | Gynecol Oncol. 2025 Jan;192:50-55. doi: 10.1016/j.ygyno.2024.11.004. Epub 2024 Nov 12. |
| URI: | https://islhd.intersearch.com.au/islhdjspui/handle/1/6332 |
| DOI: | 10.1016/j.ygyno.2024.11.004 |
| Journal Title: | Gynecol Oncol |
| Appears in Collections: | Research publications from current and former ISLHD staff. |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.